Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma

NCT01281917 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkins Lymphoma

Interventions

DRUG: Velcade
DRUG: Temsirolimus

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]
[object Object]
[object Object]